Australia's most trusted
source of pharma news
Friday, 29 March 2024
Posted 30 June 2022 AM
Pharma has ranked highly against other sectors in discussing Environmental, Social and Governance (ESG) investment this year, although an analyst at GlobalData has urged caution.
According to a recent analysis of investment discussions within ESG company filings, GlobalData found pharma ranked fourth, with oil & gas, power, and financial services coming out on top.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.